TEVA Trading Analysis - 09/16/2026 02:56 PM — TRU-SENTIMENT

News Headlines & Context:

Recent news headlines for TEVA include:

• Teva Pharmaceutical Industries Ltd. (TEVA) announced a settlement with the U.S. Department of Justice regarding allegations of misbranding and off-label promotion of certain medications.
• TEVA reported strong quarterly earnings, beating analyst expectations and citing increased sales of its key medications.
• The company announced a partnership with a leading research institution to develop new treatments for a range of diseases.

These headlines suggest that TEVA is actively addressing regulatory concerns, delivering strong financial performance, and investing in research and development.

Fundamental Analysis:

Based on the provided FUNDAMENTALS data:

• Revenue: $14,104,000,000
• Trailing EPS: $0.60
• Trailing P/E: 65.42
• Price-to-Book: 11.77
• Debt-to-Equity: 4.14
• Return on Equity (ROE): 9.14%
• Gross Margin: 64.41%
• Operating Margin: 11.36%
• Profit Margin: 5.03%

TEVA's financials indicate a relatively high P/E ratio, suggesting potential overvaluation. However, the company's strong gross and operating margins, along with a healthy ROE, demonstrate solid financial performance. The high debt-to-equity ratio may be a concern.

Current Market Position:

Current price: $38.88

Recent price action: The stock has shown an upward trend, with the current price near the upper end of its recent range.

Support and resistance levels:

• Support: $35.12 (50-day SMA)
• Resistance: $39.52 (30-day high)

Technical Analysis:

SMA trends:

• 5-day SMA: $38.06
• 20-day SMA: $37.26
• 50-day SMA: $35.12

The stock is above its 5, 20, and 50-day SMAs, indicating a bullish trend.

RSI (14): 55.49, near neutral territory.

MACD: 0.75 (MACD), 0.6 (Signal), 0.15 (Histogram), showing a bullish crossover.

Bollinger Bands: The stock is near the upper band, indicating potential overbought conditions.

30-day high/low: $39.52 / $33.89, with the stock near the upper end of the range.

True Sentiment Analysis (Delta 40-60 Options):

Overall sentiment: Bullish

Call vs. Put dollar volume: 99.5% call volume, indicating strong bullish conviction.

Pure directional positioning suggests near-term expectations are bullish.

Key Price Levels:

• Support: $35.12 (50-day SMA)
• Resistance: $39.52 (30-day high)
• Entry: $37.50
• Target: $40.00
• Stop Loss: $34.50

25-Day Price Forecast:

TEVA is projected for $40.50 to $42.20

Based on current trends, momentum, and indicators, the stock is expected to continue its upward trajectory, with potential resistance at $42.00.

Defined Risk Strategy Recommendations:

Based on the price forecast, consider the following strategies:

• Bull Call Spread: Buy TEVA 261009C00039000 (1.41), Sell TEVA 261009C00041000 (0.35), Net Debit: 1.06, Max Profit: 0.94, Breakeven: 40.06
• Iron Condor: Sell TEVA 261009C00038000 (1.90), Buy TEVA 261009C00040000 (0.92), Sell TEVA 261009P00036000 (0.91), Buy TEVA 261009P00034000 (0.41), Net Credit: 1.58

Risk Factors:

• Technical warning signs: Overbought conditions, potential Bollinger Band squeeze.
• Sentiment divergences: None apparent.
• Volatility and ATR considerations: ATR 14: 1.22, indicating moderate volatility.

Summary & Conviction Level:

Overall bias: Bullish

Conviction level: High

One-line trade idea: TEVA appears poised for continued upside, driven by bullish technicals and sentiment.